Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

    Best Selling Products

    BioNewsCast Press Release Distribution Service

    BioNewsCast Press Release Distribution Service

     

    3rd Annual Stability Testing Conference

    3rd Annual Stability Testing Conference

     

    Next-Gen Sequencing Trends 2009

    Next-Gen Sequencing Trends 2009

     

    Competitor Analysis: c-MET/HGF Inhibitors

    Competitor Analysis: c-MET/HGF Inhibitors

     

    The Japanese Pharmaceutical Market 2008-2023

    The Japanese Pharmaceutical Market 2008-2023

     

    New Products

    Japanese Pharmaceutical Market 2009-2024

    Japanese Pharmaceutical Market 2009-2024

     

    3rd Annual Lyophilisation Conference

    3rd Annual Lyophilisation Conference

     

    The Global Bioinformatics Market: Market size, forecasts and company profiles

    The Global Bioinformatics Market: Market size, forecasts and company profiles

     

    Pharmaceutical Mergers and Acquisitions (PH133)

    Pharmaceutical Mergers and Acquisitions (PH133)

     

    Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

    Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

     

    Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

    Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

     

    The Global Analgesics Market 2009-2024

    The Global Analgesics Market 2009-2024

     

    Competitor Analysis: Coagulation Factors

    Competitor Analysis: Coagulation Factors

     

    Competitor Analysis: PDGF-R Agonists and Antagonists

    Competitor Analysis: PDGF-R Agonists and Antagonists

     

    World Market for Addiction Disorders, 2009-2016

    World Market for Addiction Disorders, 2009-2016

     

    BioPortfolio | Kalorama Reports |  Anesthesia Drugs Worldwide Markets

    Anesthesia Drugs Worldwide Markets

    Anesthesia Drugs Worldwide Markets


    The number of procedures requiring anesthetic administration continues to climb with the growing and aging population in many regions of the world. The population of the world plays an important role in the growing incidence and prevalence of disease and will reflect positively on growth for anesthesia drugs.

    This Kalorama Information report - Anesthesia Drugs: Worldwide Markets - focuses on three primary segments of anesthesia:

    General Anesthesia (Inhalation, Parenteral and Rectal)

    Local Anesthesia (Parenteral

    Adjunctive Therapies in Anesthesia

    The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product.

    The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

    The issues and trends addressed in the anesthesia drug market include:

    Regulation of Anesthesia Drugs

    Dentistry and Anesthesia

    Anesthesia and Pediatric Applications

    Anesthesia and Benefits to Depressed Patients

    Anesthesia and Sleep

    Gender Differences in Anesthesia Reaction

    Trends in Conscious Sedation

    The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study

    Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

    All market data pertains to the world market at the manufacturers’ level. The base year for data was 2006. Historical data is provided for the years 2004 and 2005, with forecast data provided for 2007 through 2011. Compound annual growth rates (CAGRs) are provided for the 2004-2006, 2006-2011 and 2004-2011 periods for each industry segment covered. Competitive analysis is provided for the year 2006 with a projected competitive analysis for 2011.

    The forecasted market analysis for 2007-2011 is based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.

    Date Published: 01/07/2007

    Number of Pages:156

    PDF Format
    Table of Contents
    Price: $2,995.00 / €2,003.66



    BioPortfolio uses RBS Worldpay Secure Server for credit card transactions